The antihypertensive efficacy of Azilsartan on Nocturnalblood pressure by automated sphygmomanometer

The antihypertensive efficacy of Azilsartan on Nocturnalblood pressure by automated sphygmomanometer - The antihypertensive efficacy of Azilsartan on Nocturnalblood pressure by automated sphygmomanometer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011403

Enrollment

Registered

2013-08-07

Start date

2013-08-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

azilsaltan to olmesartan azilsaltan to olmesartan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatients Patients who signed to participate in this clinical trial. Hypertension patients who are taking olmesartan

Exclusion criteria

Exclusion criteria: A history of myocardial infarction within 1 week A history of cerebrovascular disorder within 3 months Serum Cr>2.0 mg/dL history of hyperergia to Azilsartan and Olmesartan or similar compounds Patients with pregnancy or with the possibility of pregnancy Patients started taking Olmesartan within 4 weeks Patients who changed the antihypertensive drugs most recently.

Design outcomes

Primary

Measure	Time frame
variation of nocturnal blood pressure	—

Countries

Japan

Contacts

Public ContactMegumi Shimada

Kitasato institute hospital Kitasato University Department of cardiology

shimadam@insti.kitasato-u.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026